|Year : 2017 | Volume
| Issue : 4 | Page : 360-364
Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study
Tauseef Ahmad1, Haroon2, Muhammad Khan3, Muhammad Mumtaz Khan4, Eyasu Ejeta5, Manoochehr Karami6, Chinenyenwa Ohia7
1 Department of Microbiology, Hazara University Mansehra 21300, Khyber Pakhtunkhwa, Islamic Republic of Pakistan; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing (210009), China
2 Department of Zoology, Shaheed Benazir Bhutto University, Sheringal Dir Upper, Khyber Pakhtunkhwa, Islamic Republic of Pakistan
3 Centre for Human Genetics, Hazara University Mansehra 21300, Khyber Pakhtunkhwa, Islamic Republic of Pakistan
4 Department of Microbiology, University of Haripur, Khyber Pakhtunkhwa, Islamic Republic of Pakistan
5 Department of Medical Laboratory Sciences, College of Health Sciences, Wollega University, Nekemte, Ethiopia
6 Modeling of Noncommunicable Diseases Research Center, Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
7 Department of Environmental Health Sciences, Faculty of Public Health, College of Medicine, University of Ibadan, Oyo State, Nigeria
|Date of Web Publication||17-Nov-2017|
Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing (210009), China
Source of Support: None, Conflict of Interest: None
Background: Tuberculosis (TB) is one of the leading causes of morbidity and mortality in Pakistan. Assessment of TB treatment outcomes, monitoring and evaluation of its risk factors in Directly Observed Treatment Short Course (DOTS) are among the major indicators of the performance of a national TB control program. Even though Pakistan ranks 5th among the 22 high-TB burden countries, there are no available data in this regard. Methods: Institution-based retrospective study was conducted to determine the treatment outcome of TB patients and investigate associated risk factors at District Head Quarter Hospital Shangla, Khyber-Pakhtunkhwa, Pakistan. Two-year record (January 2011 to December 2012) of TB clinic of the hospital was reviewed. A total of 493 patients' complete information was reviewed in the study period. Results: Of these, 42.19% were smear-positive pulmonary TB (PTB), 35.09% were smear-negative PTB, and 22.72% were extra-PTB (EPTB). The overall prevalence of smear-positive PTB was 42.19% (95% confidence interval [CI]: 37.9–46.2). Records of the treatment outcome showed that 192 (38.94%) were cured, 276 (55.98%) completed treatment, 13 (2.6%) defaulted, 9 (1.8%) died, 1 (0.2%) treatment failure, and 1 (0.2%) had transferred to other facilities. The overall mean treatment success rate of the TB patients was 94.93%. TB age and TB form or baseline smear were significantly associated with unsuccessful treatment outcome. The risk of unsuccessful outcome was significantly lower among TB patients age <14 years (Adjusted odds ratio [AOR] = 0.118, 95% CI: 0.022–0.644), and PTB (smear positive: AOR = 0.125, 95% CI: 0.023–0.669; Smear negative: AOR = 0.024, 95% CI: 0.003–0.205) compared to their counterpart. Conclusion: The treatment success rate was high and match the World Health Organization criteria. To sustain the effective implementation of DOTS in the area, effective management, and diagnosis should be given for EPTB.
Keywords: Directly observed treatment short course, Pakistan, treatment outcome, tuberculosis
|How to cite this article:|
Ahmad T, Haroon, Khan M, Khan MM, Ejeta E, Karami M, Ohia C. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study. Int J Mycobacteriol 2017;6:360-4
|How to cite this URL:|
Ahmad T, Haroon, Khan M, Khan MM, Ejeta E, Karami M, Ohia C. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study. Int J Mycobacteriol [serial online] 2017 [cited 2019 Jun 18];6:360-4. Available from: http://www.ijmyco.org/text.asp?2017/6/4/360/218636
| Introduction|| |
Tuberculosis (TB) is considered a disease of poverty. The prevalence of TB is high in low-income countries than developed nations. According to the global report from the World Health Organization (WHO); among the 22 high TB-burden countries in the world, Pakistan ranks fifth. Majority of the new cases (60%) of TB in the world are attributable to India, Indonesia, China, Nigeria, Pakistan, and South Africa. The global progress of TB prevention depends on major advances in TB prevention and care in these countries. The incidence of TB (includes HIV + TB) in Pakistan was 270 (175–386) per 100,000 population according to 2016 WHO report. Pakistan is also facing a challenge of growing number of multidrug-resistance TB (MDR-TB) annually. The incidence of MDR/RR-TB in the country was 14 (8.5–19) per 100,000 populations according to the latest WHO report. However, low case registration is also observed. According to statistic of the National TB control programme, in the year 2013, approximately 12,997 drug-resistant TB cases were reported, of the total registered cases only 1570 (13%) cases were enrolled for the treatment. This low number of enrollment for treatment is a major factor to spread the disease more frequently in the country and is considered a serious threat for the control and elimination of TB., In Pakistan, the rate of MDR-TB varies from 2.3% in untreated individuals and 17.9% in individuals who have been previously treated for TB, which is an alarming signal for the country.
Pakistan is listed among countries with high prevalence of TB; the availability of Directly Observed Treatment Short Course (DOTS) services provides a good foundation for the initiation and expansion of TB control strategies in Pakistan. However, there is a dearth of epidemiological data regarding TB in the country, especially in the province of Khyber-Pakhtunkhwa. Literature search revealed that no such study was carried out in district Shangla of Khyber-Pakhtunkhwa. Accordingly, the current study was designed to determine treatment outcome and factors affecting treatment outcome of TB.
| Methods|| |
Included all suspected TB patients, registered at DHQ hospital, Shangla, from January 2011 to December 2012.
A hospital-based retrospective study was designed.
Inclusion and exclusion criteria
Suspected individuals of TB who were enrolled at DHQ hospital, Shangla, from January 2011 to December 2012 were included in the study, whereas patients of TB who enrolled in private or other government health centers of the entire district were excluded from the study.
In the present study, main outcome of interest was treatment success rate of all types of TB patients.
For data collection, data collection tool was designed based on the variables including both dependent and independent. Data were collected from the secondary source of TB patients registration record. Variables of interest were gender, age, type of TB (i.e., the record showed that the patients was either smear-positive pulmonary TB [PTB], smear-negative PTB, and extra-PTB [EPTB]) as independent variables, whereas outcome variables were treatment outcome (i.e., the record showed that the patient was either cured, treatment completed, died, treatment failure, treatment after default, transfer out, and no record) and treatment success (i.e., the record showed that the patient was either cured and treatment completed).
Data processing and statistical analysis
After collecting the data, data were organized and arranged categorically. The data were presented in the form of tables. The data were entered in Microsoft Excel sheet, cleaned, and analyzed using statistical package for the social sciences (SPSS) software (IBM SPSS Statistics Version 20, IBM, USA, 2011) for Windows. Descriptive statistics was determined including frequencies and percentage. To check the significant association between dependent and independent variables odds ratio with 95% confidence interval (CI) was used using binary and multivariate logistic regression model. P < 0.05 was considered as statistically significant.
The study protocol was reviewed and approved by the Institution Ethical Review Board of Department of Microbiology, Hazara University Mansehra, Pakistan. A formal letter was written from Department to the Medical Superintendent of DHQ hospital, Shangla, for conducting the study.
| Results|| |
In the current study, a total of 493 cases of registered TB patients were included, of which (52.5%) were males and (47.5%) were females, at DHQ Hospital, Shangla, Khyber-Pakhtunkhwa, Pakistan, during the 2-year period from 2011 to 2012. Of the total cases, 42.2% were smear-positive PTB, 35.1% smear-negative PTB, and 22.7% EPTB. In total, 36.11% of TB cases were reported in ages 15–30 years. In terms of patient's recruitment, 93.5% patients were identified as new cases and 4.1% were relapse. Higher number of cases 51.7% were reported in 2012 than 2011 [Table 1].
|Table 1: Characteristics of the study participants attending directly observed treatment short course services at District Head Quarter Hospital, Shangla (2011.2012)|
Click here to view
In terms of treatment outcome, 192 (39.0%) were cured, 276 (56.0%) treatment completed, 9 (1.8%) died, 1 (0.2%) had treatment failure, 13 (2.6%) defaulted, and 1 (0.2%) transferred out. The death rate declined slightly from 2011 to 2012. On the other side, default rate increased in 2012 from 2011. The treatment success in all type of TB cases was slightly decreased in 2012 than 2011 [Table 2].
|Table 2: Treatment outcomes of tuberculosis patients attending directly observed treatment short course services at District Head Quarter Hospital, Shangla (2011-2012), n (%)|
Click here to view
After adjusting for potential predicating factors for unsuccessful treatment outcome, the result reveals a lower treatment unsuccessful among 0–14-year-old study participants (Adjusted odds ratio [AOR] 0.118, [95% CI, 0.022–0.644]) comparing to > 60 years old. Furthermore, there is lower treatment unsuccessful among patients with smear-positive PTB AOR 0.125, (95% CI, 0.023–0.669) and smear-negative PTB (AOR 0.024, [95% CI, 0.003–0.205]) compared to EPTB [Table 3].
|Table 3: Factor associated with treatment success rate of tuberculosis in DHQ Hospital, Shangla, (2011-2012)|
Click here to view
| Discussion|| |
The current study provides information about treatment outcomes of TB and associated risk factors during 2011–2012 at DHQ Hospital, Shangla. In the present study, a total of 493 TB patients were registered, of which 52.5% were male and 47.5% were female. High number of cases of all the forms of TB were recorded in males, though there was no statistically significant difference when compared to cases recorded in female participants of the study. The 2016 global TB report indicates that TB incidence is equally distributed between males and females Pakistan-wide. Our results agree with the previous studies; Sunday et al. reported a high number of cases in males (60.0%), likewise in a study conducted by Ahmad et al. at Chakdara Town, Dir (Lower), Pakistan, reported high number of cases of TB in males. Likewise, from other regions similar reports have been documented; the studies conducted in South Ethiopia and Gambella Regional Hospital, Western Ethiopia, notified high number of cases in male patients 55.8% and 54.5%, respectively., Similarly, Adejumo et al. and Ahmad et. al. reported a higher proportion of males 59.9% and 50%, respectively, among identified cases of TB in Lagos, Nigeria, and Karachi, Pakistan, respectively. The present study finding is in contrast with some other studies.,,,
In the current study, overall prevalence of smear-positive PTB was reported as 42.19% (95% CI: 37.9–46.2), which is similar to other studies. The previous studies conducted in nearby areas of the study area i.e District Dir (lower), Dargai, District Malakand, and Barikot Swat, Pakistan, reported 44.41%, 40.08%, and 40.28% cases of smear-positive PTB, respectively.,, In addition, a study conducted in Ethiopia reported the prevalence of smear-positive PTB as 40.9%. The overall mean treatment success rate of the TB patients was 94.93%. Patient age and TB form or baseline smear were significantly associated with unsuccessful treatment outcome. The risk of unsuccessful outcome was significantly lower among TB patients age <14 years (AOR = 0.118, 95% CI: 0.022–0.644), and PTB (Smear positive: AOR = 0.125, 95% CI: 0.023–0.669; Smear negative: AOR = 0.024, 95% CI: 0.003–205)comparing to EPTB.
Similarly, high treatment success rate was recorded in the previous studies.,, On the other hand, in contrast to our study lower treatment success rate was reported in previously published international studies.,,,,,,,,,,,,,,,,
According to our finding, the overall death rate was (1.83%), which decreased in the year 2012; this is in contrast to the report of Sisay et al. that recorded a higher death rate of 3.9%. Overall default rate was 2.64%; over the study period an increase in the default rate was seen; this finding is in agreement with the earlier studies, but highly contrasts with the findings reported by Ahmad et al. that reported a default incidence of 42%. This may be due to weak smear follow-up, tracing mechanism, and low level of knowledge and awareness about infectious diseases among the local inhabitant of the study area. It is important to address defaulting and drop-out as it is one of the preventable factors responsible for DOTS failure. Moreover, defaulters are usually at higher risk of increased morbidity and mortality and they also pose potential threats to the community as a whole. In the present study, information about housing, occupation, education, and other sociocultural was not determined which may also affect the treatment outcome of TB patients.
| Conclusion|| |
The high treatment success rate was recorded and meets the WHO criteria. To sustain the effective implementation of DOTS in the area, effective management, and diagnosis should be stressed for EPTB.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
World Health Organization. Global TB Report 2016. World Health Organization Geneva; 2016.
Khurram M, Khaar HT, Fahim M. Multidrug-resistant tuberculosis in Rawalpindi, Pakistan. J Infect Dev Ctries 2012;6:29-32.
World Health Organization. Global TB Report. 2012 World Health Organization Geneva; 2012.
National TB Control Program. Epidemiological review of TB in Pakistan; 2013.
Safdar N. MDR-TB in Pakistan: A challenge in hand. Pak J Med Res 2014;53:54-5.
Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A, Mangi R, et al.
Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: Identification of at risk groups. Trans R Soc Trop Med Hyg 2010;104:511-7.
Khan WM, Smith H, Qadeer E, Hassounah S. Knowledge and perceptions of national and provincial tuberculosis control programme managers in Pakistan about the WHO stop TB strategy: A qualitative study. JRSM Open 2016;8:1-9. 2054270416675084.
Sunday O, Oladimeji O, Ebenezer F, Akintunde B, Abiola TO, Saliu A, et al.
Treatment outcome of tuberculosis patients registered at DOTS centre in Ogbomoso, Southwestern Nigeria: A 4-year retrospective study. Tuberc Res Treat 2014;2014:201705.
Ahmad T, Ullah N, Ahmad K. A descriptive study of tuberculosis in Chakdara Town Pakistan. Asian J Nat Appl Sci 2013;2:98-103.
Shargie EB, Lindtjørn B. DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: A retrospective trend analysis. BMC Public Health 2005;5:62.
Adejumo OA, Daniel OJ, Otesanya AF, Adejumo EN. Determinants of health system delay at public and private directly observed treatment, short course facilities in Lagos State, Nigeria: A cross-sectional study. Int J Mycobacteriol 2016;5:257-64. [Full text]
Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N, et al.
Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study. Int J Mycobacteriol 2012;1:137-42. [Full text]
Demeke D, Legesse M, Bati J. Trend of tuberculosis and treatment outcomes in Gambella Region with special emphasize on Gambella Regional hospital, Western Ethiopia. Mycobact Dis 2013;3:2.
Ahmad T, Zohaib, Daud M, Zaman Q, Saifullah, Jadoon MA, et al
. Prevalence of tuberculosis infection in general population of district Dir (Lower) Pakistan. Middle East J Sci Res 2015;23:14-7.
Ahmad T, Jadoon MA, Haroon, Khattak MN. Prevalence of sputum smear positive pulmonary tuberculosis at Dargai, District Malakand, Pakistan: A four year retrospective study. Egypt J Chest Dis Tuberc 2016a; 65:461-4.
Ahmad T, Muhammad, Haroon, Majid A, Ullah N, Ullah T. Treatment outcomes of suspected tuberculosis patients at Civil Hospital Barikot Swat, Pakistan: (A case study). Sci Int (Lahore) 2016b;28:423-5.
Sisay S, Mengistu B, Erku W, Woldeyohannes D. Ten years' experience of directly observed treatment short-course (DOTS) in Gambella regional state, Ethiopia: An evaluation of tuberculosis control program. Int J Mycobacteriol 2016;5 Suppl 1:S117-8.
Ahmad T, Jadoon MA. Cross sectional study of pulmonary tuberculosis at Civil Hospital Thana, District Malakand Khyber Pakhtunkhwa Pakistan. World J Zool 2015;10:161-7.
Yassin MA, Datiko DG, Shargie EB. Ten-year experiences of the tuberculosis control programme in the Southern Region of Ethiopia. Int J Tuberc Lung Dis 2006;10:1166-71.
Shargie EB, Lindtjørn B. Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med 2007;4:e37.
Anuwatnonthakate A, Limsomboon P, Nateniyom S, Wattanaamornkiat W, Komsakorn S, Moolphate S, et al.
Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS One 2008;3:e3089.
Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U, et al.
Treatment outcome of tuberculosis patients at Gondar university teaching hospital, Northwest Ethiopia. A five – Year retrospective study. BMC Public Health 2009;9:371.
Ibn YS, Abdulganiyu G, Halima M, Jamilu M, Tom MG. Directly observed treatment short-course for tuberculosis: A three year survey of the treatment outcome in a Teaching Hospital in Northeastern Nigeria. Int Res J Pharm 2012;3:243-5.
Berhe G, Enquselassie F, Aseffa A. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC Public Health 2012;12:537.
Ismail I, Bulgiba A. Determinants of unsuccessful tuberculosis treatment outcomes in Malaysian HIV-infected patients. Prev Med 2013;57 Suppl:S27-30.
Getahun B, Ameni G, Medhin G, Biadgilign S. Treatment outcome of tuberculosis patients under directly observed treatment in Addis Ababa, Ethiopia. Braz J Infect Dis 2013;17:521-8.
Beza MG, Wubie MT, Teferi MD, Getahun YS, Bogale SM, Tefera SB. A five years tuberculosis treatment outcome at KollaDiba health center, Dembia District, Northwest Ethiopia: A retrospective cross sectional analysis. J Infect Dis Ther 2013;1:1-6.
Ayeno HD, Regasa BM, Lenjisa JL, Umeta GT, Woldu MA. A three years tuberculosis treatment outcome at Adama Hospital of Medical College, South East Ethiopia, a retrospective cross-sectional analysis. Int J Pharm Biol Sci Res Dev 2014;2:2347-4875.
Tadesse S, Tadesse T. Treatment success rate of tuberculosis patients in Dabat, Northwest Ethiopia. Health 2014;6:306-10.
Dolly AE, Iloghalu IC, Azuike EC, Obi DC, Mbanuzuru VA, Nwabuezeand SA, et al
. Outcome of tuberculosis treatment in tertiary hospital in South Eastern Nigeria. Int Invent J Med Med Sci 2015;2:17-22.
Ejeta E, Chala M, Arega G, Ayalsew K, Tesfaye L, Birhanu T, et al.
Outcome of tuberculosis patients under directly observed short course treatment in Western Ethiopia. J Infect Dev Ctries 2015;9:752-9.
Gebrezgabiher G, Romha G, Ejeta E, Asebe G, Zemene E, Ameni G, et al.
Treatment outcome of tuberculosis patients under directly observed treatment short course and factors affecting outcome in Southern Ethiopia: A five-year retrospective study. PLoS One 2016;11:e0150560.
Chaudhry LA, Zamzami M, Aldin S, Pazdirek J. Clinical consequences of non-compliance with directly observed therapy short course (DOTS): Story of a recurrent defaulter. Int J Mycobacteriol 2012;1:99-103. [Full text]
[Table 1], [Table 2], [Table 3]